在多细胞血症的当代挑战从患者和医生的角度来看,维拉管理
Andrew T Kuykendall1, Jennifer T Fine2, Marina Kremyanskaya3
1Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Clinical lymphoma, myeloma & leukemia
|May 15, 2024
概括
多细胞血症 (PV) 管理有效地降低了凝血风险,但通常会使患者频繁的瘤切除和症状负担. 通过减少瘤手术的需求来改善生活质量是PV治疗的关键目标.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 多细胞血症 (PV) 是一种慢性骨髓增殖性新生体,其特征是JAK/STAT通路的激活.
- 光伏管理旨在降低血栓形成风险,通常通过治疗性瘤切除术来保持血值低于45%.
- 目前的治疗方法虽然可以控制血红素,但往往无法缓解炎症症状,并对患者的生活质量产生负面影响.
研究的目的:
- 探索多细胞血病 (PV) 管理中的挑战.
- 审查当前光伏管理策略对患者生活质量的影响.
- 确定改善光伏处理模式的机会.
主要方法:
- 对当前多细胞血病 (PV) 管理策略的文献综述.
- 分析PV,JAK/STAT通路激活和患者症状之间的关系.
- 评估治疗性瘤切除和细胞减少疗法的作用和患者经验.
主要成果:
- 在减少血栓事件的同时,PV管理往往会导致患者的生活质量下降,原因是症状和繁重的瘤切除术.
- 标准的细胞还原疗法,如氧尿素和干扰素,在改善症状负担方面有效性有限.
- 经常进行血红素控制所必需的瘤切除术,限制了患者的自主权,并且往往耐受不佳.
结论:
- 目前的多细胞血病 (PV) 治疗重点是降低血栓形成风险,但往往会损害患者的生活质量.
- 需要制定PV管理策略,以改善症状负担并减少对瘤手术的依赖.
- 未来的研究应该追求疾病修饰疗法和短期战略,以提高PV患者的福祉.
相关概念视频
Disorders of Erythrocytes
929
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
929
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
198
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
198
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
157
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


